Technological Center “NovaMedica Innotech” started its activities in April 2017 in Moscow. It is a 100% subsidiary of the pharmaceutical company NovaMedica which was established by Rusnano, state investment corporation, and Domain Association (USA), venture capital company. The center was created to develop new drugs and pilot production of solid dosage forms in accordance with the GMP standards.
NovaMedica Innotech has a unique set of innovative technological platforms for the development and production of modern competitive and effective medicines. Specialists of the R&D Center of NovaMedica Innotech develop own original products and carry out a number of projects within contracts with Russian and foreign partners.
Due to the highly qualified staff, cooperation with leading global R&D centers and leaders in various segments of the pharmaceutical industry, NovaMedica Innotech is the center of competence transfer in the field of drug development in Russia in accordance with the best global practices of GLP, GMP.
![]() |
![]() |
![]() |
New polymer coating for improved cancer targeting of nanomedicine
20 May 2022
Preparation is key: the role of scientific due diligence in successful partnerships
20 May 2022
mRNA Unlocked: How Technology Convergence Is Driving the Next Wave
19 May 2022
Researchers develop battery-free, smart contact lens that delivers glaucoma drugs on demand
18 May 2022